Latest News- Celiac Diseases Drugs Market: First line treatment is expected to lead the Therapy segment during 2025-2029

The Celiac Diseases Drugs Market is being driven by Higher consumption of gluten-containing food

The Celiac Diseases Drugs Market is expected to grow at a CAGR of 23.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1505 million. The celiac diseases drugs market is poised for expansion through strategic inorganic growth initiatives. These include mergers and acquisitions, partnerships, and regional acquisitions, which will boost research and development for new molecules and advance the clinical pipeline of celiac disease treatments. Notably, Takeda and Zedira's collaboration and licensing agreement for the investigational therapy ZED1227/TAK-227, a Phase 2b treatment for celiac disease, exemplifies this trend. Such strategic alliances will likely fortify market consolidation in the future. 

Get more information on Celiac Diseases Drugs Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Therapy
  • First line treatment
  • Second-line treatment
• Route Of Administration
  • Oral
  • Parenteral
• Distribution Channel
  • Hospitals and specialty clinics
  • Specialty pharmacies
  • Retail pharmacies
  • Online platforms
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Higher consumption of gluten-containing food
• Increasing prevalence of celiac diseases
• Government initiatives

However, the market also witnesses some limitations, which are as follows:

• Poor diagnosis
• Complexity of disease
• Long-term sustainability

Benefits of Buying Global Celiac Diseases Drugs Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Celiac Diseases Drugs Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Celiac Diseases Drugs Market is significantly influenced by various factors including the adoption of a gluten-free lifestyle, certification and labeling of gluten-free products, expansion of gluten-free restaurant options, and growth in gluten-free travel. Rising awareness, research, and funding from organizations like the Celiac Disease Foundation also impact the market. The gluten-free food industry continues to innovate, while understanding of celiac disease's epidemiology, prevalence, genetics, immunology, and pathophysiology advances. Celiac disease prognosis remains challenging, but ongoing research holds promise for improved treatments.

Market Research Overview

The Celiac Diseases Drugs Market is a significant segment of the global pharmaceuticals industry, encompassing companies involved in the research and development (R&D) or production of both generic and non-generic medications. According to Technavio, the global pharmaceuticals market size is determined by the consolidated revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the growth of this market include the increasing global population aging, with approximately one-quarter of the US population projected to be over 60 years old by 2050, and Europe reaching a similar demographic milestone by 2030. This demographic shift is expected to fuel demand for various pharmaceutical products, including those used to treat Celiac Disease, Gluten Sensitivity, and Gluten Intolerance, as well as other health conditions prevalent among older populations.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/